Marburg outbreak is reported in Uganda, threatening to complicate Ebola response in region

Authored by
marburg virus

Uganda has detected what appears to be a localized outbreak of Marburg virus disease, with two cases identified in a single family, according to a source familiar with the situation, although the Ugandan government had not yet publicly confirmed the outbreak at the time of publication. The development comes as Uganda is already responding to a cross-border outbreak of Bundibugyo Ebola, raising concerns that managing two viral hemorrhagic fever outbreaks simultaneously could complicate public health efforts. The article notes that Marburg and Ebola spread through similar routes but that there are currently no licensed Marburg vaccines, though several candidates are in development. It also highlights Uganda's strong record of containing hemorrhagic fever outbreaks while noting the government's tendency to be cautious about publicly disclosing them, particularly given the importance of tourism and ongoing efforts to persuade other countries to ease travel restrictions related to the Ebola outbreak.

#GWSMHS is recruiting. Interested in global health? Visit https://redcap.link/marburg to volunteer for a new vaccine study on Marburg virus. This study requires 9 visits over 7 months.

Latest News

The GW VRU is a site for a clinical trial to examine Pfizer's new C. diff vaccine.
This was a phase 2, randomized, open-label, non-placebo controlled trial to evaluate two partial doses o the Modified Vaccinia Ankara-Bavarian Nordin (MVA-BN) vaccine for protection against mpox.
This was a phase 1, double-blind trial to examine the safety and immunogenicity of a replication-competent recombinant vesicular stomatitis virus-vectored vaccine to reduce the risk of infection and severe illness from Lassa Fever.